Trials / Unknown
UnknownNCT03805425
PiXL for Correction of Hyperopia
Photorefractive Intrastromal Corneal Crosslinking (PiXL) for Correction of Hyperopia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Gemini Eye Clinic · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical study aims to investigate the efficacy and safety of PiXL in the refractive correction of low hyperopia.
Detailed description
This clinical study aims to investigate the efficacy and safety of PiXL in the refractive correction of low hyperopia.Slightly modified settings from previously published study is applied to eyes with low hyperopia with an expected refractive change of 0.75 D. Aim is to evaluate the refractive outcome of this procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | PiXL | The system is set to deliver 30 mW/cm2 UVA irradiance in pulsed intervals of 1 second on and 1 second off to 5 to 9 mm diameter corneal annulus. Total energy delivered is 15J. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2020-12-01
- Completion
- 2021-03-01
- First posted
- 2019-01-15
- Last updated
- 2021-02-03
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT03805425. Inclusion in this directory is not an endorsement.